Home / Healthcare / CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Indonesia

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Indonesia

Published: Nov 2014 | No Of Pages: 172 | Published By: GlobalData

GlobalData, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Indonesia. It is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Indonesia, identifying key trends in the healthcare market and providing insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical devices market. It is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalDatas team of industry experts.

In 2013, Indonesias population stood at 251 million, up from 238 million in 2008. The major factors that contributed to the growth in the population are an increase in net migration and a drop in the death rate. The countrys pharmaceutical market was estimated to have been worth $5 billion in 2013 and is expected to reach $9.9 billion by 2020 at a projected Compound Annual Growth Rate (CAGR) of 10.2%. In 2010, according to US Commercial Service estimates, the countrys medical device market was worth $573m.

The positive trends in the Indonesian healthcare market can primarily be attributed to

  • Increasing coverage of healthcare insurance
  • Improved access to healthcare facilities

Scope

  • Overview of the pharmaceutical and medical device markets, including size, segmentation and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical and medical device markets: PT Kalbe Farma Tbk, PT Tempo Scan Pacific Tbk, Kimia Farma, PT
  • Darya-Varia Laboratoria Tbk and PT Indofarma Tbk
    An insightful review of the reimbursement and regulatory landscape, covering the healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
  • Detailed analysis of the political and economic environment, including economic indicators, demographics, healthcare infrastructure and healthcare expenditureAn overview of the opportunities for and challenges to growth in the healthcare market

Reasons to buy

The report will enhance your decision-making capability by allowing you to

  • Develop business strategies through an understanding of the trends shaping and driving the healthcare market
  • Drive revenue by understanding the key trends, reimbursement and regulatory policies, pharmaceutical and medical device market segments and companies likely to impact the healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment and strategic partnership
  • Identify, understand and capitalize on the opportunities and challenges in the healthcare market

1 Table of Contents 6
1.1 List of Tables 9
1.2 List of Figures 12

2 Introduction 16
2.1 GlobalData Report Guidance 16

3 Overview of Pharmaceutical and Medical Device Markets 17
3.1 Pharmaceutical Market 17
3.1.1 Market Overview 17
3.1.2 Supply Channels 20
3.1.3 Market Segments 22
3.1.4 Major Drug Classes 26
3.1.5 Major Players 33
3.2 Medical Device Market 53
3.2.1 Market Overview 53
3.3 Market Drivers and Barriers 55
3.3.1 Drivers 55
3.3.2 Barriers 56

4 Market Access 59
4.1 Reimbursement and Payer Landscape 59
4.1.1 Overview of Healthcare System 59
4.1.2 Reimbursement Process 60
4.1.3 Overview of Insurance Providers 62
4.1.4 Patient Share of Healthcare Expenditure 65
4.1.5 Healthcare Price Trends 66
4.1.6 Pricing Policies 67
4.2 Regulatory Landscape 68
4.2.1 Overview of Regulatory Agencies 68
4.2.2 Market Authorization Procedure for Pharmaceutical Products 69
4.2.3 New Medical Device Approval Process 73
4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 75
4.2.5 Licensing Process for Pharmaceutical Exports and Imports 76
4.2.6 Intellectual Property Rights 77
4.2.7 Clinical Trial Regulations 81
4.2.8 Pharmaceutical Advertising Regulations 82
4.2.9 Pharmacy Regulations 83
4.2.10 Labeling and Packaging Regulations 83

5 Country Analysis 85
5.1 Political Environment 85
5.1.1 Political Structure 85
5.1.2 Analysis of the Current Political Environment 86
5.1.3 Healthcare Policy Initiatives 87
5.2 Economic Landscape 89
5.3 Economic Indicators 92
5.3.1 Gross Domestic Product 92
5.3.2 Gross National Income 96
5.3.3 Inflation 98
5.3.4 Currency Exchange Rate 101
5.3.5 Foreign Direct Investment 102
5.3.6 Foreign Exchange Reserves 104
5.3.7 Trade Balance 105
5.3.8 Government Structural Balance 107
5.3.9 Government Gross Debt 108
5.3.10 Major Industries 110
5.4 Demographics 112
5.4.1 Population 112
5.4.2 Education and Literacy 126
5.4.3 Employment 129
5.4.4 Disease Burden 130
5.5 Healthcare Infrastructure 133
5.5.2 Healthcare Parameters 138
5.5.3 Environmental Health 140
5.5.4 Healthcare Personnel 145
5.6 Healthcare Expenditure 148
5.6.1 Overview of Healthcare Expenditure 148
5.6.2 Major Components of Healthcare Expenditure 150
5.6.3 Healthcare Expenditure Distribution 151
5.7 Trade Associations 153
5.7.1 International Pharmaceutical Manufacturers Group 153
5.7.2 Indonesia Pharmaceutical Association 153
5.7.3 Indonesia Medical Association 153
5.8 Trade Fairs 153

6 Opportunities and Challenges 155
6.1 Opportunities 155
6.2 Challenges 157

7 Appendix 159
7.1 Abbreviations 159
7.2 Bibliography 161
7.3 Research Methodology 169
7.3.1 Coverage 170
7.3.2 Secondary Research 170
7.3.3 Forecasts 171
7.3.4 Expert Panel 171
7.4 Disclaimer 171

Table 1: Pharmaceutical Market, Indonesia, Revenue ($bn), 2008-2013 19
Table 2: Pharmaceutical Market, Indonesia, Revenue Forecast ($bn), 2014-2020 20
Table 3: Pharmaceutical Market, Indonesia, Distribution Channel Price Margins (%), 2014 21
Table 4: Pharmaceutical Market, Indonesia, Pharmaceutical Distribution (%), 2010 22
Table 5: Pharmaceutical Market, Indonesia, OTC, Revenue ($bn), 2008-2013 24
Table 6: Pharmaceutical Market, Indonesia, Pharmaceutical Market Share (%), 2008-2013 25
Table 7: Pharmaceutical Market, Indonesia, Major Therapeutic Areas (%), 2005 26
Table 8: Pharmaceutical Market, Indonesia, Antibiotics Market Segments (%), 2005 28
Table 9: Pharmaceutical Market, Indonesia, Respiratory Drug Market Segments (%), 2005 29
Table 10: Pharmaceutical Market, Indonesia, Neuromuscular Drug Market Segments (%), 2005 30
Table 11: Pharmaceutical Market, Indonesia, Vitamins and Minerals Market Segment (%), 2005 31
Table 12: Pharmaceutical Market, Indonesia, Dermatological Drug Market Segments (%), 2005 32
Table 13: Major Products, PT Kalbe Farma Tbk, Revenue, 2012 34
Table 14: Major Products, PT Tempo Scan Pacific Tbk, 2014 39
Table 15: Major Products, PT Darya-Varia Laboratoria Tbk, 2014 48
Table 16: Major Products, PT Indofarma Tbk, 2014 51
Table 17: Overview of Insurance Providers, Indonesia, Health Insurance Coverage (%), 2011 63
Table 18: Overview of Insurance Providers, Indonesia, Public Health Insurance Schemes Overview, 2010 64
Table 19: Overview of Insurance Providers, Indonesia, Patient Share of Healthcare Expenditure (%), 2008-2013 66
Table 20: Overview of Insurance Providers, Indonesia, Healthcare Inflation (%), 2008-2013 67
Table 21: Regulatory Landscape, Indonesia, New Drug Registration Categories, 2014 71
Table 22: Regulatory Landscape, Indonesia, Patent Application Fees, 2014 79
Table 23: Impact of Natural Calamities, Indonesia, 1996-2009 90
Table 24: Economic Indicators, Indonesia, GDP per Capita ($), 2008-2013 93
Table 25: Economic Indicators, Indonesia, GDP per Capita ($), Forecast, 2014-2020 94
Table 26: Economic Indicators, Indonesia, GDP Annual Growth (%), 2008-2013 95
Table 27: Economic Indicators, Indonesia, GDP Annual Growth (%), Forecast, 2014-2020 96
Table 28: Economic Indicators, Indonesia, GNI per Capita ($), 2008-2013 97
Table 29: Economic Indicators, Indonesia, Average Consumer Price Index, 2008-2013 99
Table 30: Economic Indicators, Indonesia, Average Consumer Price Index, Forecast, 2014-2020 99
Table 31: Economic Indicators, Indonesia, Average Consumer Price Index Annual Change (%), 2008-2013 100
Table 32: Economic Indicators, Indonesia, Average Consumer Price Index, Annual Change (%), Forecast, 2014-2020 101
Table 33: Economic Indicators, Indonesia, Currency Exchange Rate (IDR/$), 2008-2013 102
Table 34: Economic Indicators, Indonesia, Foreign Direct Investment ($bn), 2008-2013 103
Table 35: Economic Indicators, Indonesia, Foreign Exchange Reserves ($bn), 2008-2013 104
Table 36: Economic Indicators, Indonesia, Imports of Goods and Services ($bn), 2008-2013 105
Table 37: Economic Indicators, Indonesia, Exports of Goods and Services ($bn), 2008-2013 106
Table 38: Economic Indicators, Indonesia, General Government Structural Balance ($bn), 2008-2013 107
Table 39: Economic Indicators, Indonesia, General Government Gross Debt ($bn), 2008-2013 109
Table 40: Economic Indicators, Indonesia, General Government Gross Debt ($bn), Forecast, 2014-2020 110
Table 41: Economic Indicators, Indonesia, Major Industries by GDP Share (%), 2012 111
Table 42: Demographics, Indonesia, Population (million), 2008-2013 112
Table 43: Demographics, Indonesia, Population (million), Forecast, 2014-2020 113
Table 44: Demographics, Indonesia, Urban and Rural Population Share (%), 2008-2013 114
Table 45: Demographics, Indonesia, Urban and Rural Population Share (%), Forecast, 2014-2020 115
Table 46: Demographics, Indonesia, Population Distribution by Age Group (%), 2008-2013 116
Table 47: Demographics, Indonesia, Population Distribution by Age Group (%), Forecast, 2014-2020 117
Table 48: Demographics, Indonesia, Births (Per 1,000 Population), 2008-2013 118
Table 49: Demographics, Indonesia, Mortality (Per 1,000 Population), 2008-2013 119
Table 50: Demographics, Indonesia, Causes of Mortality (‘000), 2008 121
Table 51: Demographics, Indonesia, Children Table 52: Demographics, Indonesia, Immunization Rate (%), 2008-2013 123
Table 53: Demographics, Indonesia, Gender Ratio (M/F), 2008-2013 124
Table 54: Demographics, Indonesia, Life Expectancy at Birth (Years), 2008-2013 125
Table 55: Demographics, Indonesia, Life Expectancy at Birth (Years), Forecast, 2014-2020 126
Table 56: Demographics, Indonesia, Illiteracy by Age Group (%), 2008-2013 127
Table 57: Demographics, Indonesia, School Enrollment by Age Group (%), 2012 128
Table 58: Demographics, Indonesia, Unemployment (%), 2008-2013 129
Table 59: Demographics, Indonesia, Causes of Hospitalization (Per 100,000 Population), 2010 131
Table 60: Demographics, Indonesia, DALY (Per 100,000 Population), 2004 132
Table 61: Healthcare Infrastructure, Indonesia, Public and Private Hospitals, 2008-2013 134
Table 62: Healthcare Infrastructure, Indonesia, Health Centers (‘000), 2008-2013 135
Table 63: Healthcare Infrastructure, Indonesia, Hospitals by Type of Care, 2011 136
Table 64: Healthcare Infrastructure, Indonesia, General Hospital Beds (‘000), 2008-2013 137
Table 65: Healthcare Infrastructure, Indonesia, Beds (Per 100,000 Population), 2008-2013 138
Table 66: Healthcare Infrastructure, Indonesia, Physicians (Per 100,000 Population), 2008-2013 139
Table 67: Environmental Health, Indonesia, CO2 Emissions (Million Metric Tons), 2008-2013 141
Table 68: Environmental Health, Indonesia, PM10 Emissions (µg/m3), 2008-2013 142
Table 69: Environmental Health, Indonesia, Access to Protected Drinking Water (%), 2010 144
Table 70: Environmental Health, Indonesia, Waste Handling (%), 2008 145
Table 71: Healthcare Personnel, Indonesia, Nurses (Per 100,000 Population), 2008-2013 146
Table 72: Healthcare Personnel, Indonesia, Pharmacists, (Per 100,000 Population), 2008-2013 147
Table 73: Healthcare Personnel, Indonesia, Dentists, (Per 100,000 Population), 2008-2013 148
Table 74: Healthcare Expenditure, Indonesia, Healthcare Expenditure (%), 2008-2013 149
Table 75: Healthcare Expenditure, Indonesia, Major Components (%), 2008 151
Table 76: Healthcare Expenditure, Indonesia, Distribution (%), 2008-2013 152
Table 77: Trade Fairs, Indonesia, Major Healthcare Trade Fairs, 2013-2014 154

Figure 1: Pharmaceutical Market, Indonesia, Revenue ($bn), 2008-2013 19
Figure 2: Pharmaceutical Market, Indonesia, Revenue Forecast ($bn), 2014-2020 20
Figure 3: Pharmaceutical Market, Indonesia, Distribution Chain, 2014 21
Figure 4: Pharmaceutical Market, Indonesia, Pharmaceutical Distribution (%), 2010 22
Figure 5: Pharmaceutical Market, Indonesia, OTC, Revenue ($bn), 2008-2013 24
Figure 6: Pharmaceutical Market, Indonesia, Pharmaceutical Market Share (%), 2008-2013 25
Figure 7: Pharmaceutical Market, Indonesia, Major Therapeutic Areas (%), 2005 26
Figure 8: Pharmaceutical Market, Indonesia, Antibiotics Market Segments (%), 2005 28
Figure 9: Pharmaceutical Market, Indonesia, Respiratory Drug Market Segments (%), 2005 29
Figure 10: Pharmaceutical Market, Indonesia, Neuromuscular Drug Market Segments (%), 2005 30
Figure 11: Pharmaceutical Market, Indonesia, Vitamins and Minerals Market Segments (%), 2005 31
Figure 12: Pharmaceutical Market, Indonesia, Dermatological Drug Market Segments (%), 2005 32
Figure 13: Healthcare Market, Indonesia, Drivers and Barriers, 2014 58
Figure 14: Market Access, Indonesia, History of Health Insurance System, 1968-2008 60
Figure 15: Market Access, Indonesia, Process for Addition to Hospital Drug Formulary, 2014 62
Figure 16: Overview of Insurance Providers, Indonesia, Health Insurance Coverage (%), 2011 63
Figure 17: Overview of Insurance Providers, Indonesia, Patient Share of Healthcare Expenditure (%), 2008-2013 66
Figure 18: Overview of Insurance Providers, Indonesia, Healthcare Inflation (%), 2008-2013 67
Figure 19: Regulatory Landscape, Indonesia, Structure of the National Agency of Drug and Food Control, 2014 69
Figure 20: Regulatory Landscape, Indonesia, New Drug Market Authorization Process, 2014 71
Figure 21: Regulatory Landscape, Indonesia, Generic Drug Market Authorization Process, 2014 73
Figure 22: Regulatory Landscape, Indonesia, Medical Device Approval Process, Indonesia, 2014 75
Figure 23: Regulatory Landscape, Indonesia, Licensing Process for Manufacturing, 2014 76
Figure 24: Regulatory Landscape, Indonesia, Structure of the Directorate General of Intellectual Property Office, 2014 78
Figure 25: Regulatory Landscape, Indonesia, Patent Approval Process, 2014 80
Figure 26: Regulatory Landscape, Indonesia, Clinical Trial Regulation Process, 2014 82
Figure 27: Economic Indicators, Indonesia, GDP Per Capita ($), 2008-2013 93
Figure 28: Economic Indicators, Indonesia, GDP per Capita ($), Forecast, 2014-2020 94
Figure 29: Economic Indicators, Indonesia, GDP Annual Growth (%), 2008-2013 95
Figure 30: Economic Indicators, Indonesia, GDP Annual Growth (%), Forecast, 2014-2020 96
Figure 31: Economic Indicators, Indonesia, GNI per Capita ($), 2008-2013 97
Figure 32: Economic Indicators, Indonesia, Consumer Price Index, 2008-2013 98
Figure 33: Economic Indicators, Indonesia, Average Consumer Price Index, Forecast, 2014-2020 99
Figure 34: Economic Indicators, Indonesia, Average Consumer Price Index, Annual Change (%), 2008-2013 100
Figure 35: Economic Indicators, Indonesia, Average Consumer Price Index, Annual Change (%), Forecast, 2014-2020 101
Figure 36: Economic Indicators, Indonesia, Currency Exchange Rate (IDR/$), 2008-2013 102
Figure 37: Economic Indicators, Indonesia, Foreign Direct Investment ($bn), 2008-2013 103
Figure 38: Economic Indicators, Indonesia, Foreign Exchange Reserves ($bn), 2008-2013 104
Figure 39: Economic Indicators, Indonesia, Imports of Goods and Services ($bn), 2008-2013 105
Figure 40: Economic Indicators, Indonesia, Exports of Goods and Services ($bn), 2008-2013 106
Figure 41: Economic Indicators, Indonesia, Government Structural Balance ($bn), 2008-2013 107
Figure 42: Economic Indicators, Indonesia, General Government Gross Debt ($bn), 2008-2013 109
Figure 43: Economic Indicators, Indonesia, General Government Gross Debt ($bn), Forecast, 2014-2020 110
Figure 44: Economic Indicators, Indonesia, Major Industries by GDP Share (%), 2012 111
Figure 45: Demographics, Indonesia, Population (million), 2008-2013 112
Figure 46: Demographics, Indonesia, Population (million), Forecast, 2014-2020 113
Figure 47: Demographics, Indonesia, Urban and Rural Population Share (%), 2008-2013 114
Figure 48: Demographics, Indonesia, Urban and Rural Population Share (%), Forecast, 2014-2020 115
Figure 49: Demographics, Indonesia, Population Distribution by Age Group (%), 2008-2013 116
Figure 50: Demographics, Indonesia, Population Distribution by Age Group (%), Forecast, 2014-2020 117
Figure 51: Demographics, Indonesia, Births (Per 1,000 Population), 2008-2013 118
Figure 52: Demographics, Indonesia, Mortality (Per 1,000 Population), 2008-2013 119
Figure 53: Demographics, Indonesia, Causes of Mortality (000), 2008 120
Figure 54: Demographics, Indonesia, Children Figure 55: Demographics, Indonesia, Immunization Rate (%), 2008-2013 123
Figure 56: Demographics, Indonesia, Gender Ratio (M/F), 2008-2013 124
Figure 57: Demographics, Indonesia, Life Expectancy at Birth (Years), 2008-2013 125
Figure 58: Demographics, Indonesia, Life Expectancy at Birth (Years), Forecast, 2014-2020 126
Figure 59: Demographics, Indonesia, Illiteracy by Age Group (%), 2008-2013 127
Figure 60: Demographics, Indonesia, School Enrollment by Age Group (%), 2012 128
Figure 61: Demographics, Indonesia, Unemployment (%), 2008-2013 129
Figure 62: Demographics, Indonesia, Causes of Hospitalization (Per 100,000 Population), 2010 130
Figure 63: Demographics, Indonesia, DALYs (Per 100,000 Population), 2004 132
Figure 64: Healthcare Infrastructure, Indonesia, Public and Private Hospitals, 2008-2013 134
Figure 65: Healthcare Infrastructure, Indonesia, Health Centers (000), 2008-2013 135
Figure 66: Healthcare Infrastructure, Indonesia, Hospitals by Type of Care, 2011 136
Figure 67: Healthcare Infrastructure, Indonesia, General Hospital Beds (000), 2008-2013 137
Figure 68: Healthcare Infrastructure, Indonesia, Beds (Per 100,000 Population), 2008-2013 138
Figure 69: Healthcare Infrastructure, Indonesia, Physicians (Per 100,000 Population), 2008-2013 139
Figure 70: Environmental Health, Indonesia, CO2 Emissions (Million Metric Tons), 2008-2013 141
Figure 71: Environmental Health, Indonesia, PM10 Emissions (g/m3), 2008-2013 142
Figure 72: Environmental Health, Indonesia, Access to Protected Drinking Water, 2010 143
Figure 73: Environmental Health, Indonesia, Waste Handling (%), 2008 144
Figure 74: Healthcare Personnel, Indonesia, Nurses (Per 100,000 Population), 2008-2013 146
Figure 75: Healthcare Personnel, Indonesia, Pharmacists, (Per 100,000 Population), 2008-2013 147
Figure 76: Healthcare Personnel, Indonesia, Dentists, (Per 100,000 Population), 2008-2013 148
Figure 77: Healthcare Expenditure, Indonesia, Healthcare Expenditure (%), 2008-2013 149
Figure 78: Healthcare Expenditure, Indonesia, Major Components (%), 2008 150
Figure 79: Healthcare Expenditure, Indonesia, Distribution (%), 2008-2013 152
Figure 80: Healthcare Market, Indonesia, Opportunities and Challenges, 2014 158

Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +